Emsam Patch
Product Images NDC 49502-902

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Emsam (NDC 49502-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Selegiline Structural Formula (Image 01)

Chemical structure of selegiline base, the active ingredient in EMSAM transdermal patches. The structure shows the molecular arrangement of selegiline.*

FDA Label Image

Figure 1: Side View Of Emsam (Image 02)

An illustration diagram showing a cross-section of the EMSAM transdermal patch, labeled to indicate three layers: the backing film at the top, the adhesive/drug layer in the middle, and the release liner at the bottom.*

FDA Label Image

Figure 2. Kaplan-meier Estimates Of Cumulative Percent Of Patients With Relapse (study 3) (Image 03)

A line graph comparing the cumulative percentage of Type I clinical depression event reappearance over 56 weeks after randomization for placebo versus selegiline treatment. The x-axis represents time in weeks, and the y-axis shows the cumulative percent of reappearance. Two lines illustrate distinct trends for placebo and selegiline groups.*

FDA Label Image

Instructions For Use Figure A (Image 04)

An instructional diagram showing recommended application sites for the EMSAM transdermal patch. It highlights the upper arm, upper chest, upper thigh, and upper back areas on a male figure from front, side, and rear views for patch placement guidance.*

FDA Label Image

Instructions For Use Figure C And Figure D (Image 05)

An illustration showing two views of the EMSAM transdermal patch. The first view shows the patch with its release liner partially peeled back, exposing the adhesive containing medicine. The patch has an outside backing on the opposite side. The second view shows the outside backing side of the patch with EMSAM branding repeated across the surface.*

FDA Label Image

Instructions For Use Figure H (Image 06)

Illustration showing a person applying an EMSAM transdermal patch to the chest area, demonstrating correct placement on the upper torso for the selegiline patch available in strengths of 6 mg/24h, 9 mg/24h, and 12 mg/24h.*

FDA Label Image

Instructions For Use Figure E (Image 07)

An instructional illustration showing hands peeling the release liner from an EMSAM transdermal patch, exposing the adhesive side with medicine for application to the skin.*

FDA Label Image

Dosage Application 6 mg/24 H (Image 08)

Illustration showing instructions for EMSAM (selegiline) transdermal patch application. It depicts recommended placement sites on the body: upper arm, upper chest, upper back, and upper thigh. Additional images show removing the release liner from the adhesive patch with medicine and applying the patch to a chest area.*

FDA Label Image

Emsam Transdermal 6 mg/24 Hour Carton Label (Image 09)

The image shows packaging for EMSAM 6 mg/24h, a selegiline transdermal system patch. The label includes the proprietary name EMSAM and generic name selegiline transdermal system, with a strength of 6 mg per 24 hours. The package contains 30 transdermal systems and is labeled for prescription use only. The labeler is listed as Mylan and Somerset Pharmaceuticals. Application instructions with diagrams for patch placement on upper arm, chest, back, or thigh are also visible.*

FDA Label Image

Dosage Application 9 mg/24 H (Image 10)

Instructional diagram showing recommended application sites for EMSAM patch, including upper arm, upper chest, upper back, and upper thigh. Additional illustrations depict how to peel the release liner from the adhesive patch containing medicine and how to apply the patch onto the skin.*

FDA Label Image

Emsam Transdermal 9 mg/24 Hour Carton Label (Image 11)

Packaging label for EMSAM 9 mg/24h transdermal system, a prescription patch containing selegiline for transdermal use. The label shows 30 transdermal systems per package, instructions for application with illustrated body sites, safety warnings including to not eat certain foods, and is distributed by Mylan Specialty L.P. and manufactured for Somerset Pharmaceuticals, Morgantown, WV, USA.*

FDA Label Image

Dosage Application 12 mg/24 H (Image 12)

An instructional illustration for EMSAM selegiline transdermal patch application. Panel 1 shows recommended patch sites on the body: upper arm, upper chest, upper back, and upper thigh. Panel 2 depicts hands peeling away the release liner from the adhesive patch containing the medicine. Panel 3 shows applying the patch to the upper chest area of the body.*

FDA Label Image

Instructions For Use Figure B (Image 13)

An instructional illustration showing hands peeling open a sealed pouch containing an EMSAM (selegiline) transdermal patch. The packaging displays the product name and active ingredient, indicating proper handling before application.*

FDA Label Image

Instructions For Use Figure F (Image 14)

An instructional illustration showing the application of an EMSAM transdermal patch (containing selegiline) on the upper chest area of a person. The hands are positioning the patch on the skin, demonstrating proper placement for use.*

FDA Label Image

Instructions For Use Figure G (Image 15)

An illustration showing a person applying an EMSAM selegiline transdermal patch on the upper chest area. The image depicts hands holding the patch and placing it on the skin, demonstrating correct patch application.*

FDA Label Image

Emsam Transdermal 12 mg/24 Hour Carton Label (Image 16)

Packaging label for EMSAM (selegiline transdermal system) 12 mg/24h patch by Viatris Specialty LLC. The carton states it contains 30 transdermal systems for transdermal use only. It includes cautionary text about not eating certain foods and instructs to read the enclosed Medication Guide. Instructions for patch application with illustrations are also visible on the label's side panel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.